DELI

Keep hope alive! We invite you to stay tuned to DMD Keep hope alive! We invite you to stay tuned to DMD
13.09.2024

Keep hope alive! We invite you to stay tuned to DMD

Keep hope alive! We invite you to stay tuned to DMD

From September 6 to 7 2024, the Porton Wecare Program accompanied the families of four Chongqing DMD patients to Shanghai to participate in the 13th China Rare Disease Summit 2024.
The summit, co-sponsored by the Chinese Organization for Rare Disorders (CORD) and Xinhua Hospital affiliated with Shanghai Jiaotong University School of Medicine, was held from September 6 to 8, 2024.

Keep hope alive! We invite you to stay tuned to DMD
Keep hope alive! We invite you to stay tuned to DMD

During the summit, we participated in the “Duchenne Muscular Dystrophy (DMD) Academic Seminar” with the families. Medical experts and representatives from biopharmaceutical companies, who have long focused on the diagnosis and treatment of DMD, were invited to share the latest research results and treatment strategies with families of DMD patients from across the country through keynote speeches, round-table forums, and other interactive sessions. The seminar aimed to provide insights into the future development directions of DMD in China, bringing more benefits to the patients.

Keep hope alive! We invite you to stay tuned to DMD

Through this summit, we have not only witnessed the rapid advancements in the field of DMD research but also the genuine care from various sectors of society towards DMD patients. All hope will come true and it will no longer be a dream.

Keep hope alive! We invite you to stay tuned to DMD

In the future, the Porton Wecare Program will continue to focus on the DMD, enabling the public's early access to good medicines!

Keep hope alive! We invite you to stay tuned to DMD

*Photo Source: Live Photos from the 13th China Rare Disease Summit

DELI

Keep hope alive! We invite you to stay tuned to DMD Keep hope alive! We invite you to stay tuned to DMD
Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025 Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
Novice

Razkriti vpogledi: poglobite se v naše globalno središče novic!

22.05.2024

Otvoritev sodobnih raziskovalno-razvojnih laboratorijev podjetja Porton za področje farmacevtskih učinkovin, malih molekul v Mengšu

  • Slovesna otvoritev sodobnih raziskovalno-razvojnih laboratorijev za farmacevtske učinkovine, male molekule podjetja Porton v Mengšu.

  • Donacija 20.000,00 EUR Občini Mengeš za obnovo poplavljenega vrtca.

  • Nova delovna mesta in nadaljnja rast na področju farmacevtskih učinkovin, malih molekul v Mengšu

Preberi novico

Cookie settings

Your current status

Show details